Desq Long
Sign in
SEC FORM 4
$32,089.20

Cue Biopharma, Inc. (CUE)

Sale of 1,144 shares at $28.05 per share.

Reporting Person Meluzio Michael Vincent · Officer Title VP, Prin. Accounting Officer · Transaction Code S

Traded Oct 12, 2026 · Disclosed Oct 14, 2026

Source: SEC Form 4 · 0002138368-26-000009 · filed 2026-10-14 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Cue Biopharma, Inc. (CUE)." Disclosed 2026-10-14. https://desqlong.com/cards/0002138368-26-000009-1 (retrieved 2026-10-15).